Joanne M. Donovan

Companies

• Edgewise Therapeutics, Inc.CMO May 4, 2021 to now¹
• Catabasis PharmaceuticalsChief Medical Officer Jun 24, 2015 to Feb 14, 2020²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEdgewise Therapeutics, Inc. EWTX8,625 shares³$326.5K at $37.85Aug 13, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Aug 13, 2026Sold 2,919 shares at $43.41 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 800 shares at $44.52 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 104 shares at $44.43 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 2,779 shares at $43.71 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Sold 2,839 shares at $43.78 of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Exercised options 7,031 shares of Edgewise Therapeutics, Inc.³
• Aug 12, 2026Exercised options 5,781 shares of Edgewise Therapeutics, Inc.³
• May 5, 2026Sold 50,000 shares at $38.57 of Edgewise Therapeutics, Inc.⁴
• May 5, 2026Exercised options 50,000 shares at $7.08 of Edgewise Therapeutics, Inc.⁴
• May 4, 2026Sold 5,230 shares at $31.29 of Edgewise Therapeutics, Inc.⁴
• Apr 1, 2026Sold 28,662 shares at $32.31 of Edgewise Therapeutics, Inc.⁵
• Apr 1, 2026Exercised options 28,662 shares at $7.08 of Edgewise Therapeutics, Inc.⁵
• Mar 31, 2026Sold 21,338 shares at $32.12 of Edgewise Therapeutics, Inc.⁶
• Mar 31, 2026Exercised options 21,338 shares at $7.08 of Edgewise Therapeutics, Inc.⁶
• Mar 27, 2026Sold 6,735 shares at $30.98 of Edgewise Therapeutics, Inc.⁷
• Mar 27, 2026Sold 9,623 shares at $30.98 of Edgewise Therapeutics, Inc.⁷
• Aug 12, 2025Sold 2,862 shares at $13.39 of Edgewise Therapeutics, Inc.⁸
• Aug 12, 2025Exercised options 5,781 shares of Edgewise Therapeutics, Inc.⁸
• May 2, 2025Sold 5,187 shares at $16.45 of Edgewise Therapeutics, Inc.⁹
• May 1, 2025Exercised options 10,417 shares of Edgewise Therapeutics, Inc.⁹
• Jan 28, 2025Sold 25,000 shares at $27.63 of Edgewise Therapeutics, Inc.¹⁰
• Jan 28, 2025Exercised options 25,000 shares at $7.08 of Edgewise Therapeutics, Inc.¹⁰
• Sep 20, 2024Sold 7,162 shares at $28.29 of Edgewise Therapeutics, Inc.¹¹
• May 2, 2024Sold 3,682 shares at $18.91 of Edgewise Therapeutics, Inc.¹²
• May 1, 2024Exercised options 10,417 shares of Edgewise Therapeutics, Inc.¹²